Lennar Corporation
NYSE: LEN-B · CONSUMER CYCLICAL · RESIDENTIAL CONSTRUCTION
Updated 2026-06-05
Lennar Corporation (LEN-B) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for LEN-B.
Valued
Valuation reasonably reflects current fundamentals. Limited margin of safety at these levels.
LEN-B historical valuation range
Where current P/E sits in LEN-B's own 5Y range.
LEN-B intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
LEN-B valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 12.76x
P/S Ratio — History
Current: 0.66x
Is LEN-B overvalued in 2026?
Lennar Corporation (LEN-B) currently trades at $84.88 per share with a market capitalization of $21,836,808,000.00. Based on our multi-factor framework, the stock trades at a fair valuation with a Smart Value Score of 53/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 12.8x, above its 5-year median of 12.1x. The PEG ratio of 0.75 suggests earnings growth is outpacing the multiple, a classic sign of undervaluation.
Looking at its own history, LEN-B is currently trading more expensive than 80% of the last 5Y on P/E. This places it in the 80th percentile of its historical range, a zone where forward returns have typically been muted.
Our discounted cash flow model estimates LEN-B's intrinsic value at $766.63 per share, against the current market price of $84.88. This implies a margin of safety of +85.37%. A meaningful cushion exists against model error, making this a reasonable risk-adjusted entry.
Financial quality is a concern. The Piotroski F-Score of 3/9 flags weakening fundamentals that deserve closer scrutiny before the valuation case can be fully trusted.
Bottom line: LEN-B trades at a fair valuation on our framework, with a Smart Value Score of 53/100. The valuation is defensible but offers no obvious bargain. Patience or a better entry price may reward disciplined buyers.
Frequently asked questions
Is LEN-B overvalued?
LEN-B scores 53/100 on our Smart Value Score (Grade C), a mixed overall profile. The DCF also shows a positive margin of safety, so price and fundamentals line up reasonably well.
What is LEN-B's fair value?
Our DCF model estimates LEN-B's intrinsic value at $766.63 per share, versus the current price of $84.88, a margin of safety of +85.37%. Fair value is the present value of the cash flows we project the business to produce, so a price below it means the market is pricing the stock below that conservative estimate.
What P/E ratio does LEN-B trade at?
LEN-B trades at a P/E of 12.8x on trailing twelve-month earnings, against a 5-year median of 12.1x. P/E is what you pay per dollar of profit, and sitting above its own median means the stock is pricier than usual relative to its earnings.
Is LEN-B a buy based on valuation?
Our Smart Value rating for LEN-B is Hold, from a Smart Value Score of 53/100 that blends growth, quality, and valuation. The profile is balanced and best suited to investors who already have a thesis. This is research to inform your decision, not personalized financial advice.
How does LEN-B's valuation compare to its history?
On P/E, LEN-B sits in the 80th percentile of its own 5Y range, historically expensive relative to where it has traded. A high percentile means today's multiple is near the top of its historical band.
What is LEN-B's Smart Value Score?
LEN-B's Smart Value Score is 53/100. It is a proprietary WallStSmart metric blending growth quality, financial health, and valuation into a single 0-100 read, and scores above 75 are rare, signaling strong multi-factor alignment.